{"id":"https://openalex.org/W2415009685","doi":null,"title":"[Secondary-reinforcing effects of opiate agonists in the mouse].","display_name":"[Secondary-reinforcing effects of opiate agonists in the mouse].","publication_year":1986,"publication_date":"1986-11-01","ids":{"openalex":"https://openalex.org/W2415009685","mag":"2415009685","pmid":"https://pubmed.ncbi.nlm.nih.gov/3031897"},"language":"ru","primary_location":{"id":"pmid:3031897","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3031897","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova","raw_type":"Comparative Study"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028959450","display_name":"Edwin E. Zvartau","orcid":"https://orcid.org/0000-0002-3597-7482","observed_orcids":["https://orcid.org/0000-0002-3597-7482"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E E Zvartau","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5022995869","display_name":"Kovalenko Vs","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V S Kovalenko","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.17099057,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"6","first_page":"1069","last_page":"76"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9169999957084656,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9169999957084656,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.07370000332593918,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/secondary-reinforcement","display_name":"secondary reinforcement","score":0.8759999871253967},{"id":"https://openalex.org/keywords/opioid-agonists","display_name":"opioid agonists","score":0.9449999928474426},{"id":"https://openalex.org/keywords/morphine","display_name":"morphine","score":0.9760000109672546},{"id":"https://openalex.org/keywords/nalorphine","display_name":"nalorphine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/pentazocine","display_name":"pentazocine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/phencyclidine","display_name":"phencyclidine","score":1.0},{"id":"https://openalex.org/keywords/shuttle-box","display_name":"shuttle box","score":0.6119999885559082},{"id":"https://openalex.org/keywords/time-asymmetry","display_name":"time asymmetry","score":0.7639999985694885},{"id":"https://openalex.org/keywords/locomotor-activity","display_name":"locomotor activity","score":0.9990000128746033},{"id":"https://openalex.org/keywords/mu-opioid-receptor","display_name":"mu-opioid receptor","score":0.9380000233650208},{"id":"https://openalex.org/keywords/dose-dependent-effects","display_name":"dose-dependent effects","score":0.6060000061988831}],"concepts":[{"id":"https://openalex.org/C2776657501","wikidata":"https://www.wikidata.org/wiki/Q2622916","display_name":"Nalorphine","level":5,"score":0.9135124087333679},{"id":"https://openalex.org/C2778140631","wikidata":"https://www.wikidata.org/wiki/Q2026938","display_name":"Opiate","level":3,"score":0.766547679901123},{"id":"https://openalex.org/C2778851735","wikidata":"https://www.wikidata.org/wiki/Q407324","display_name":"Phencyclidine","level":4,"score":0.7534716129302979},{"id":"https://openalex.org/C2780802079","wikidata":"https://www.wikidata.org/wiki/Q415793","display_name":"Pentazocine","level":3,"score":0.6599412560462952},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.6418681740760803},{"id":"https://openalex.org/C2910977262","wikidata":"https://www.wikidata.org/wiki/Q421797","display_name":"Opiate receptors","level":5,"score":0.46972954273223877},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4058458209037781},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3822972774505615},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.3546956181526184},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.3512219786643982},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3213300406932831},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.23330965638160706},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22574681043624878},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.07402661442756653}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003214","descriptor_name":"Conditioning, Classical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009020","descriptor_name":"Morphine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009269","descriptor_name":"Nalorphine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009294","descriptor_name":"Narcotics","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010423","descriptor_name":"Pentazocine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010622","descriptor_name":"Phencyclidine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011957","descriptor_name":"Receptors, Opioid","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D012054","descriptor_name":"Reinforcement, Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:3031897","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3031897","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova","raw_type":"Comparative Study"},{"id":"mag:2415009685","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3031897","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.6240000128746033,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2023624958","https://openalex.org/W2413652858","https://openalex.org/W2020469758","https://openalex.org/W2072955127","https://openalex.org/W2098179807","https://openalex.org/W2436348148","https://openalex.org/W2133479791","https://openalex.org/W2043130405","https://openalex.org/W2071912703","https://openalex.org/W2081635971"],"abstract_inverted_index":{"Comparative":[0],"examination":[1],"of":[2,5,20,42,45,53,62,70,87],"secondary-reinforcing":[3,38,47,85],"properties":[4],"opiate":[6,88],"agonists":[7],"morphine,":[8],"nalorphine,":[9],"pentazocine":[10],"and":[11,30,58,73,81],"phencyclidine":[12,29],"was":[13],"carried":[14],"out":[15],"on":[16],"mice":[17],"using":[18],"procedure":[19],"place":[21],"preference":[22],"conditioning":[23],"in":[24,51,55,64],"an":[25],"automatic":[26],"shuttle-box.":[27,66],"Morphine,":[28],"pentaxocine":[31],"(but":[32],"not":[33],"nalorphine)":[34],"produced":[35],"strong":[36],"dose-dependent":[37],"effects.":[39],"Special":[40],"features":[41],"behavioural":[43],"manifestations":[44],"their":[46],"action":[48],"were":[49],"analyzed":[50],"aspect":[52],"changes":[54],"temporal":[56],"asymmetry":[57],"attendant":[59],"locomotor":[60],"activity":[61],"animals":[63],"the":[65,68,71],"On":[67],"basis":[69],"obtained":[72],"literature":[74],"data,":[75],"it":[76],"is":[77],"suggested":[78],"that":[79],"mu-":[80],"sigma-opiate":[82],"receptors":[83],"mediate":[84],"effects":[86],"agonists.":[89]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}